Marco Roncador
Zurich, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Validation of the ELN2024 and Mayo Genetic Risk Models in an External Cohort of 352 Patients With Newly Diagnosed AML Receiving Less-Intensive Therapies.
Journal: American journal of hematology
Published: June 10, 2025
Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma.
Journal: Blood cancer journal
Published: July 09, 2024
Mutational patterns in therapy-related acute lymphoblastic leukemia subgroups: one step closer to unveiling the genetic odyssey.
Journal: Leukemia & lymphoma
Published: February 22, 2024
Intrapatient competition of VEXAS syndrome and CML clones.
Journal: Blood advances
Published: May 24, 2023
Introducing innovative cellular therapies into the clinic: a 2-year retrospective experience of a chimeric antigen receptor T-cell programme at a single centre in Switzerland.
Journal: Swiss medical weekly
Published: June 26, 2022
Low PEEP Mechanical Ventilation and PaO2/FiO2 Ratio Evolution in COVID-19 Patients.
Journal: SN comprehensive clinical medicine
Published: July 16, 2021
Loss of ribonuclease DIS3 hampers genome integrity in myeloma by disrupting DNA:RNA hybrid metabolism.
Journal: The EMBO journal
Published: February 16, 2021
DROSHA is recruited to DNA damage sites by the MRN complex to promote non-homologous end joining.
Journal: Journal of cell science
Published: June 02, 2020
Radiation oncologists role, training and perceptions in palliative care: a systematic review.
Journal: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
Published: May 25, 2020
Last Updated: 09/26/2026